Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 100 Records) |
| Query Trace: Memory and CD4[original query] |
|---|
| CpG Island Methylator Phenotype Modulates the Immune Response of the Tumor Microenvironment and Influences the Prognosis of Pancreatic Cancer Patients. Journal of oncology 2021 12 2021 2715694. Ning Gang, Li Yongqiang, Chen Wenji, Tang Wenjuan, Shou Diwen, Luo Qingling, Chen Huiting, Zhou Yongji |
| Brief Report: Polymorphisms in CAMKK2 may Influence Domain-Specific Neurocognitive Function in HIV+ Indonesians Receiving ART. Journal of acquired immune deficiency syndromes (1999) 2021 12 89 (1): 115-119. Gaff Jessica, Estiasari Riwanti, Diafiri Dinda, Halstrom Samuel, Kamerman Peter, Price Patric |
| Combination of Tumor Mutational Burden and Specific Gene Mutations Stratifies Outcome to Immunotherapy Across Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma. Frontiers in genetics 2021 12 12 756506. Peng Ying-Peng, Wang Rong, Liu Qiao-Dan, Xu Xi-Wei, Wei Wei, Huang Xiao-Tao, Peng Xiao-Mou, Liu Zhi-Ga |
| Bioinformatic Analysis of Immune Significance of RYR2 Mutation in Breast Cancer. BioMed research international 2021 12 2021 8072796. Xu Zhiquan, Xiang Ling, Wang Rong, Xiong Yongfu, Zhou He, Gu Haitao, Wang Jijian, Peng Linglo |
| Identification of an Immune-Related Signature Predicting Survival Risk and Immune Microenvironment in Gastric Cancer. Frontiers in cell and developmental biology 2021 11 9 687473. Dai Shuang, Liu Tao, Liu Xiao-Qin, Li Xiao-Ying, Xu Ke, Ren Tao, Luo Fe |
| Construction of a redox-related gene signature for overall survival prediction and immune infiltration in non-small-cell lung cancer. Frontiers in molecular biosciences 2022 9 9 942402. Miao Ti-Wei, Yang De-Qing, Gao Li-Juan, Yin Jie, Zhu Qi, Liu Jie, He Yan-Qiu, Chen X |
| A novel prognostic index of stomach adenocarcinoma based on immunogenomic landscape analysis and immunotherapy options. Experimental and molecular pathology 2022 9 128 104832. Xue Weijie, Dong Bingzi, Wang Yixiu, Xie Yuwei, Li Pu, Gong Zhiqi, Niu Zhaoji |
| Transcriptome analysis of immune cells from Behçet's syndrome patients: the importance of IL-17-producing cells and antigen-presenting cells in the pathogenesis of Behçet's syndrome. Arthritis research & therapy 2022 8 24 (1): 186. Okubo Mai, Sumitomo Shuji, Tsuchida Yumi, Nagafuchi Yasuo, Takeshima Yusuke, Yanaoka Haruyuki, Shirai Harumi, Kobayashi Satomi, Sugimori Yusuke, Maeda Junko, Hatano Hiroaki, Iwasaki Yukiko, Shoda Hirofumi, Okamura Tomohisa, Yamamoto Kazuhiko, Ota Mineto, Fujio Keis |
| The Relationship of Pyroptosis-Related Genes, Patient Outcomes, and Tumor-Infiltrating Cells in Bladder Urothelial Carcinoma (BLCA). Frontiers in pharmacology 2022 8 13 930951. Xie Ruiyan, Xie Ming, Zhu Litong, Chiu Joanne W Y, Lam Wayne, Yap Desmond Y |
| Four-copy number alteration (CNA)-related lncRNA prognostic signature for liver cancer. Scientific reports 2022 Aug 12 (1): 14261. Cheng Zhenyun, Guo Yan, Sun Jingjing, Zheng L |
| An immune-related gene prognostic risk index for pancreatic adenocarcinoma. Frontiers in immunology 2022 8 13 945878. Su Yang, Qi Ruoshan, Li Lanying, Wang Xu, Li Sijin, Zhao Xuan, Hou Rui, Ma Wen, Liu Dan, Zheng Junnian, Shi Mi |
| Multidimensional Molecular Profiling of Metastatic Triple-Negative Breast Cancer and Immune Checkpoint Inhibitor Benefit. JCO precision oncology 2022 7 6 e2100413. Barroso-Sousa Romualdo, Forman Juliet, Collier Katharine, Weber Zachary T, Jammihal Tejas R, Kao Katrina Z, Richardson Edward T, Keenan Tanya, Cohen Ofir, Manos Michael P, Brennick Ryan C, Ott Patrick A, Hodi F Stephen, Dillon Deborah A, Attaya Victoria, O'Meara Tess, Lin Nancy U, Van Allen Eliezer M, Rodig Scott, Winer Eric P, Mittendorf Elizabeth A, Wu Catherine J, Wagle Nikhil, Stover Daniel G, Shukla Sachet A, Tolaney Sara |
| Comprehensive analysis of tumor mutation burden and immune microenvironment in prostate cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2022 Jun . Liao Junqun, Ye Yuan, Xu Xur |
| Abundance of reactive oxygen species (ROS) is associated with tumor aggressiveness, immune response, and worse survival in breast cancer. Breast cancer research and treatment 2022 5 194 (2): 231-241. Oshi Masanori, Gandhi Shipra, Yan Li, Tokumaru Yoshihisa, Wu Rongrong, Yamada Akimitsu, Matsuyama Ryusei, Endo Itaru, Takabe Kazua |
| Response to Severe Acute Respiratory Syndrome Coronavirus 2 Initial Series and Additional Dose Vaccine in Patients With Predominant Antibody Deficiency. The journal of allergy and clinical immunology. In practice 2022 4 10 (6): 1622-1634.e4. Barmettler Sara, DiGiacomo Daniel V, Yang Nancy J, Lam Tiffany, Naranbhai Vivek, Dighe Anand S, Burke Kristin E, Blumenthal Kimberly G, Ling Morris, Hesterberg Paul E, Saff Rebecca R, MacLean James, Ofoman Onosereme, Berrios Cristhian, St Denis Kerri J, Lam Evan C, Gregory David, Iafrate Anthony John, Poznansky Mark, Lee Hang, Balazs Alejandro, Pillai Shiv, Farmer Jocelyn |
| Identification of the Immune Signatures for Ovarian Cancer Based on the Tumor Immune Microenvironment Genes. Frontiers in cell and developmental biology 2022 4 10 772701. Shen Xiaoyan, Gu Xiao, Ma Ruiqiong, Li Xiaoping, Wang Jianl |
| Effect of MUC16 mutations on tumor mutation burden and its potential prognostic significance for cutaneous melanoma. American journal of translational research 2022 3 14 (2): 849-862. Wang Zi, Hou Huimin, Zhang Haomin, Duan Xingwu, Li Lingling, Meng Lingfe |
| Identification of a glycolysis-related gene signature for predicting prognosis in patients with hepatocellular carcinoma. BMC cancer 2022 2 22 (1): 142. Kong Junjie, Yu Guangsheng, Si Wei, Li Guangbing, Chai Jiawei, Liu Yong, Liu J |
| A special prognostic indicator: tumor mutation burden combined with immune infiltrates in lung adenocarcinoma with TP53 mutation. Translational cancer research 2022 2 10 (9): 3963-3978. Fu Jing, Li Yaonan, Li Cuidan, Tong Yuyang, Li Mengyuan, Cang Shundo |
| Systemic immune microenvironment and regulatory network analysis in patients with lung adenocarcinoma. Translational cancer research 2022 2 10 (6): 2859-2872. Liu Libao, Xu Shilei, Huang Lei, He Jinyuan, Liu Gang, Ma Shaohong, Weng Yimin, Huang Shaoho |
| Prognostic and Immunological Role of FAT Family Genes in Non-Small Cell Lung Cancer. Cancer control : journal of the Moffitt Cancer Center 0 29 10732748221076682. Feng Zhenxing, Yin Yan, Liu Bin, Zheng Yafang, Shi Dongsheng, Zhang Hong, Qin Jianw |
| Integrated genomic analyses of hepatocellular carcinoma. Hepatology international 2022 12 17 (1): 97-111. Chang Ya-Sian, Tu Siang-Jyun, Chen Hong-Da, Hsu Ming-Hon, Chen Yu-Chia, Chao Dy-San, Chung Chin-Chun, Chou Yu-Pao, Chang Chieh-Min, Lee Ya-Ting, Yen Ju-Chen, Jeng Long-Bin, Chang Jan-Gow |
| An EGFR L858R mutation identified in 1862 Chinese NSCLC patients can be a promising neoantigen vaccine therapeutic strategy. Frontiers in immunology 2022 12 13 1022598. Lin Jing, Liu Jun, Hao Shi-Guang, Lan Bin, Zheng Xiao-Bin, Xiong Jia-Ni, Zhang Ying-Qian, Gao Xuan, Chen Chuan-Ben, Chen Ling, Huang Yu-Fang, Luo Hong, Yi Yu-Ting, Yi Xin, Lu Jian-Ping, Zheng Xiong-Wei, Chen Gang, Wang Xue-Feng, Chen |
| Non?small cell lung cancer carrying PBRM1 mutation suggests an immunologically cold phenotype leading to immunotherapy failure even with high TMB. Scientific reports 2022 12 12 (1): 20734. Miao Xia-Ye, Wu Hao, Ye Bi-Cheng, Yi Qian-Wen, Lin Fang-Nan, Wang Yi-Lin, Ren Chuan-Li, Jiang Yan-Fang, Li A |
| A novel cuproptosis-related gene signature of prognosis and immune microenvironment in head and neck squamous cell carcinoma cancer. Journal of cancer research and clinical oncology 2022 11 149 (1): 203-218. Jiang Xu, Ke Jing, Jia Lifeng, An Xiang, Ma Haiyu, Li Zhongwan, Yuan W |
| High frequency of CD8 escape mutations in elite controllers as new obstacle for HIV cure. Virulence 2022 10 13 (1): 1713-1719. Navarrete-Muñoz María A, Ramos Ricardo, Holguín África, Cabello Alfonso, Górgolas Miguel, Benito José M, Rallón Nor |
| DNA Repair and Replication-Related Gene Signature Based on Tumor Mutation Burden Reveals Prognostic and Immunotherapy Response in Gastric Cancer. Journal of oncology 2022 1 2022 6469523. Zhang Lei, Hu Dahai, Huangfu Shuchen, Zhou Jiaxin, Wang Wei, Liu Shijin, Tang Hui, Pan Jinghua, Pan Yunlo |
| Comprehensive biomarker analysis of long-term response to trastuzumab in patients with HER2-positive advanced gastric or gastroesophageal adenocarcinoma. European journal of cancer (Oxford, England : 1990) 2023 2 183 119-130. Porth Isabel, Hirsch Daniela, Ceribas Yonca, Weidner Philip, Weichert Wilko, Götze Thorsten Oliver, Perner Sven, Luley Kim, Heyer Christian Moritz, de la Torre Carolina, Hofheinz Ralf-Dieter, Lorenzen Sylvie, Gaiser Ti |
| A new immune signature for survival prediction and immune checkpoint molecules in non-small cell lung cancer. Frontiers in oncology 2023 2 13 1095313. Han Shuai, Jiang Dongjie, Zhang Feng, Li Kun, Jiao Kun, Hu Jingyun, Song Haihan, Ma Qin-Yun, Wang Ji |
| Clinical and immunological features of an APLAID patient caused by a novel mutation in PLCG2. Frontiers in immunology 2023 2 14 1014150. Peng Qi, Luo Dong, Yang Yi, Zhu Yinghua, Luo Qingming, Chen Huan, Chen Dapeng, Zhou Zhongjun, Lu Xiaom |
- Page last reviewed:Feb 1, 2023
- Page last updated:May 30, 2023
- Content source: